Overview

Genomic sequencing is reshaping the diagnostic, drug development and treatment landscapes across cancer, rare diseases, and infectious diseases. Join us in person to explore the future of precision medicine enabled by genomic sequencing on Friday 24th May at Old Billingsgate, London.

This one-day event is packed with expert-led sessions exploring how genomic sequencing has the potential to transform patient outcomes and in turn, enhance the value delivered by healthcare systems globally.

Our speakers and panellists will provide diverse perspectives on the applications of genomic sequencing in settings ranging from leading healthcare institutions to drug manufacturing. They will also discuss potential future challenges and opportunities to enable the true patient and wider population impacts to be realised.

Who should attend?

Attendance is highly recommended for individuals or organisations who are interested in, or are actively engaged in, the advancement of precision medicine.
The following are encouraged to participate:

• Clinical Researchers & Physician-Scientists
• Industry
• Population Health & Hospitals
• Regulatory Authorities, Policymakers, Payers
• Non-Governmental Organisations (including those focused on Global Health, Clinical Societies, Patient Advocacy)

Why attend?

Through a series of plenary talks, clinical research deep dives, and panel discussions we will:

• Uncover the potential impact of genomic sequencing on patient care
• Reflect on key challenges in precision medicine and explore multi-disciplinary solutions
• Inspire a collective vision for the future implementation of precision medicine across healthcare systems globally
• Highlight examples of how genomic sequencing is transforming the drug development pipeline

CPD accreditation under review.